Hartmut Koeppen

This inventor holds 19 USPTO granted patents and 23 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignees: Genentech, Inc., Ventana Medical Systems, Inc., Genetech, Inc.. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hartmut Koeppen. Retrieved from https://idiyas.com/inventor/hartmut-koeppen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 23)

% Patents Active = 63.2

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 13)

Average Co-Inventor Count = 6.3

ph-index = 7

Forward Citations = 378(Granted Patents)

Location History:

Berkeley, CA (US) (2004 - 2014)
South San Francisco, CA (US) (2019)
San Mateo, CA (US) (2015 - 2022)

Company Filing History:

Ventana Medical Systems, Inc.

Spring Bioscience Corporation

patents

where one patent can have more than one assignee

Years Active: 2004-2026

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12675880 - Transformation of histochemically stained images into synthetic immunohistochemistry (IHC) images (2026-07-07),

2. 12630635 - POLYNUCLEOTIDES ENCODING ANTI-PD-L1 ANTIBODIES (2026-05-19),

3. 12570745 - BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS (2026-03-10),

4. 11530269 - Anti-PD-L1 antibodies and diagnostic uses thereof (2022-12-20),

5. 11299544 - Biomarkers and methods of treating PD-1 and PD-L1 related conditions (2022-04-12),

6. 10689445 - Anti-PD-L1 antibodies and diagnostic uses thereof (2020-06-23),

7. 10240207 - Cancer treatment with c-met antagonists and correlation of the latter with HGF expression (2019-03-26),

8. 8993249 - Anti-neuropilin antibodies and methods of use (2015-03-31),

9. 8728480 - Methods for the treatment of tumors expressing TAT123 or naturally occurring variants thereof (2014-05-20),

10. 8388973 - Compositions and methods for the treatment of tumor of hematopoietic origin (2013-03-05),

11. 8278042 - Compositions and methods for the diagnosis and treatment of tumor (2012-10-02),

12. 7888478 - Compositions and methods for the treatment of tumor of hematopoietic origin (2011-02-15),

13. 7858330 - Compositions and methods for the treatment of tumor of hematopoietic origin (2010-12-28),

14. 7803915 - Antibody compositions for the diagnosis and treatment of tumor (2010-09-28),

15. 7749504 - Anti-TAT188 antibodies (2010-07-06),

Title: The Innovative Journey of Hartmut Koeppen

Introduction:

Hartmut Koeppen is a visionary inventor based in Berkeley, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Hartmut Koeppen's recent patents include cutting-edge advancements in artificial intelligence, renewable energy systems, and sustainable transportation solutions.

Career Highlights:

With a career spanning over two decades, Hartmut Koeppen has established himself as a leading figure in the tech industry, with a focus on creating solutions that address pressing global challenges.

Collaborations:

Throughout his career, Hartmut Koeppen has collaborated with top research institutions, leading companies, and innovative startups to bring his ideas to life and make a positive impact on society.

Conclusion:

Hartmut Koeppen's relentless pursuit of innovation and his passion for creating a better future through technology continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.